Apyx Medical Corporation (APYX) financial statements (2021 and earlier)

Company profile

Business Address 5115 ULMERTON ROAD
CLEARWATER, FL 33760
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments42444651596267
Cash and cash equivalents42444651596267
Receivables17151412986
Inventory, net of allowances, customer advances and progress billings4556576
Inventory4556576
Other undisclosed current assets3444422
Total current assets:66687074777982
Noncurrent Assets
Finance lease, right-of-use asset011111 
Operating lease, right-of-use asset000000 
Property, plant and equipment7667776
Intangible assets, net (including goodwill)      0
Goodwill      0
Deposits noncurrent assets      0
Other noncurrent assets1110000
Total noncurrent assets:8888887
TOTAL ASSETS:74757882858789
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities999101297
Accounts payable2223212
Accrued liabilities7778976
Debt000000 
Due to related parties 0000  
Other undisclosed current liabilities000   0
Total current liabilities:91010111298
Noncurrent Liabilities
Long-term debt and lease obligation0111110
Long-term debt, excluding current maturities     00
Finance lease, liability000000 
Operating lease, liability0000000
Liabilities, other than long-term debt111110 
Deferred revenue11   0 
Other liabilities00111  
Total noncurrent liabilities:1111110
Total liabilities:1011111213108
Stockholders' equity
Stockholders' equity attributable to parent64646770717781
Common stock0000000
Additional paid in capital61605958575654
Retained earnings34813152126
Stockholders' equity attributable to noncontrolling interest00     
Total stockholders' equity:64646770717781
TOTAL LIABILITIES AND EQUITY:74757882858789

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues11745887
Cost of revenue
(Cost of Goods and Services Sold)
(4)(2)(2)(2)(2)(3)(2)
Gross profit:8523654
Operating expenses(10)(9)(8)(10)(12)(10)(9)
Other operating income (expense), net(0)(0)(0)0(0)0(0)
Other undisclosed operating income (loss)000(0)0(0)0
Operating loss:(2)(4)(6)(7)(6)(5)(4)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
0(0)(0)1(0)10
Interest and debt expense(0)(0)(0)(0)   
Other undisclosed loss from continuing operations before equity method investments, income taxes    (0)  
Loss from continuing operations before equity method investments, income taxes:(2)(4)(6)(7)(6)(4)(4)
Other undisclosed income from continuing operations before income taxes00000  
Loss from continuing operations before income taxes:(2)(4)(6)(7)(6)(4)(4)
Income tax expense (benefit)01150(0)(0)
Loss from continuing operations:(2)(4)(5)(2)(6)(4)(4)
Other undisclosed loss before gain (loss) on sale of properties(0)      
Loss before gain (loss) on sale of properties:(2)(4)(5)(2)(6)(4)(4)
Other undisclosed net income0      
Net loss:(2)(4)(5)(2)(6)(4)(4)
Net income attributable to noncontrolling interest00     
Net loss available to common stockholders, diluted:(2)(4)(5)(2)(6)(4)(4)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(2)(4)(5)(2)(6)(4)(4)
Comprehensive loss:(2)(4)(5)(2)(6)(4)(4)
Comprehensive income, net of tax, attributable to noncontrolling interest00     
Comprehensive loss, net of tax, attributable to parent:(2)(4)(5)(2)(6)(4)(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: